Literature DB >> 23766460

Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment.

Dominic Paquin-Proulx1, Bianca A N Santos, Karina I Carvalho, Myrthes Toledo-Barros, Ana Karolina Barreto de Oliveira, Cristina M Kokron, Jorge Kalil, Markus Moll, Esper G Kallas, Johan K Sandberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23766460      PMCID： PMC3682345          DOI： 10.1182/blood-2013-04-499442

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood.

Authors:  A Dzionek; A Fuchs; P Schmidt; S Cremer; M Zysk; S Miltenyi; D W Buck; J Schmitz
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

2.  Characterization of human blood dendritic cell subsets.

Authors:  Kelli P A MacDonald; David J Munster; Georgina J Clark; Andrzej Dzionek; Juergen Schmitz; Derek N J Hart
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 3.  Novel insights into lipid antigen presentation.

Authors:  Gennaro De Libero; Lucia Mori
Journal:  Trends Immunol       Date:  2012-02-16       Impact factor: 16.687

Review 4.  Common variable immunodeficiency (CVID): exploring the multiple dimensions of a heterogeneous disease.

Authors:  Ulrich Salzer; Susanne Unger; Klaus Warnatz
Journal:  Ann N Y Acad Sci       Date:  2012-02-02       Impact factor: 5.691

Review 5.  Langerhans cells - dendritic cells of the epidermis.

Authors:  Nikolaus Romani; Sandra Holzmann; Christoph H Tripp; Franz Koch; Patrizia Stoitzner
Journal:  APMIS       Date:  2003 Jul-Aug       Impact factor: 3.205

Review 6.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

Review 7.  The surprising diversity of lipid antigens for CD1-restricted T cells.

Authors:  D Branch Moody
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 8.  Common variable immunodeficiency: a new look at an old disease.

Authors:  Miguel A Park; James T Li; John B Hagan; Daniel E Maddox; Roshini S Abraham
Journal:  Lancet       Date:  2008-08-09       Impact factor: 79.321

9.  IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa.

Authors:  Anna Smed-Sörensen; Markus Moll; Tan-Yun Cheng; Karin Loré; Anna-Carin Norlin; Leif Perbeck; D Branch Moody; Anna-Lena Spetz; Johan K Sandberg
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113
  9 in total
  10 in total

1.  Vitamin D treatment modulates immune activation in cystic fibrosis.

Authors:  T Pincikova; D Paquin-Proulx; J K Sandberg; M Flodström-Tullberg; L Hjelte
Journal:  Clin Exp Immunol       Date:  2017-05-24       Impact factor: 4.330

2.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

3.  Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.

Authors:  Dominic Paquin-Proulx; Anna Gibbs; Susanna M Bächle; Antonio Checa; Andrea Introini; Edwin Leeansyah; Craig E Wheelock; Douglas F Nixon; Kristina Broliden; Annelie Tjernlund; Markus Moll; Johan K Sandberg
Journal:  J Immunol       Date:  2016-08-01       Impact factor: 5.422

4.  Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.

Authors:  Milica Mitrevski; Ramona Marrapodi; Alessandro Camponeschi; Cristina Lazzeri; Laura Todi; Isabella Quinti; Massimo Fiorilli; Marcella Visentini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 5.  Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects.

Authors:  Andrea Matucci; Enrico Maggi; Alessandra Vultaggio
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

Review 6.  Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

Authors:  Dominic Paquin-Proulx; Johan K Sandberg
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

7.  Expression of CD1a and Type-1 Polarization Are Dissociated in Human Monocyte-Derived Dendritic Cells.

Authors:  Brigitta Mester; Evelyn Bauer; Catherine E Wood; Ian F Hermans; Olivier Gasser
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

8.  Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.

Authors:  Dominic Paquin-Proulx; Nathália Silveira Barsotti; Bianca A N Santos; Ana Karolina B B Marinho; Cristina M Kokron; Karina I Carvalho; Myrthes T Barros; Jorge Kalil; Douglas F Nixon; Esper G Kallas
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.

Authors:  Matthieu Perreau; Selena Vigano; Florence Bellanger; Céline Pellaton; Guillaume Buss; Denis Comte; Thierry Roger; Christine Lacabaratz; Pierre-Alexandre Bart; Yves Levy; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2014-09-15       Impact factor: 14.307

10.  Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

Authors:  Isabella Quinti; Milica Mitrevski
Journal:  Front Immunol       Date:  2017-06-16       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.